Navigation Links
Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial
Date:11/22/2013

er 31, 2012 and its Form 10-Q for the quarterly period ended September 30, 2013.  The reader is cautioned not to rely on any forward-looking statements made by Regeneron.  Regeneron does not undertake any obligation to update publicly any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise.Sanofi Contacts: Media RelationsInvestor RelationsJack CoxSebastien MartelTel.: + (33) 1 53 77 46 4Tel.: + (33) 1 53 77 45 45mr@sanofi.comir@sanofi.comRegeneron Contacts:  Media RelationsInvestor RelationsSandy SextonManisha Narasimhan, Ph.D.Tel: 1 (914) 847-3358Tel: 1 (914) 847-5126sandra.sexton@regeneron.commanisha.narasimhan@regeneron.com


'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Sanofi US Launches Collaborate Activate Innovation Challenge
3. Sanofi Pasteur to add 2D barcode to six more vaccines
4. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
5. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
6. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
7. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
8. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
9. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
10. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
11. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... --  Wellcentive , the industry leader in end-to-end ... today being named one of the four finalists ...  Sponsored by Intel, the world leader in computing ... companies developing leading-edge technology and unique approaches to ... Wellcentive,s Mason Beard , senior vice ...
(Date:11/18/2014)... Nov. 18, 2014 Respiratory Motion and IMI ... medical device and services providers in Japan ... Respiratory Motion,s innovative respiratory depression monitor, the ExSpiron™. As ... are working together to connect the clinical community in ... history of bringing innovative medical devices and new technology ...
(Date:11/18/2014)... 18, 2014 Investor-Edge has initiated coverage ... ), Geron Corporation (NASDAQ: GERN ), Tekmira Pharmaceuticals ... GALE ), and XOMA Corporation (NASDAQ: ... accessed at: http://investor-edge.com/register . The US markets ... as the Dow Jones Industrial Average finished at 17,647.75, up ...
Breaking Medicine Technology:Wellcentive Named Finalist for 2014 Intel Innovation Award 2Wellcentive Named Finalist for 2014 Intel Innovation Award 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5
(Date:11/21/2014)... TopConsumerReviews.com recently awarded their highest ... in the relief of depression symptoms. ... sadness and depression each year and are unable ... prescription drugs can produce worse side effects than ... and require regular follow-up visits with a doctor. ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 RankingBySEO has ... manage the online reputation of lawyers, and the company ... has announced the service for lawyers since it receives ... online reputation in big numbers. So far, the company ... and law firms in different parts of the world, ...
(Date:11/21/2014)... First Choice Emergency Room ... new facility is located at 225 E. Parkwood Drive, ... are pleased to join the Friendswood community and look ... here,” said Dr. Siddiqi, Facility Medical Director of First ... the opening, First Choice Emergency Room made a donation ...
(Date:11/21/2014)... November 21, 2014 M3 Global Research ... healthcare professional panel, today announced two important leadership changes to ... DasGupta as President of Market Research, Americas and the promotion ... , Ms. DasGupta joined M3 in 2011 and ... recently Head of Sales. Roni has over 17 years ...
(Date:11/21/2014)... Dennis Thompson HealthDay Reporter ... or obese women who get pregnant are much more likely ... an adult, new research suggests. But it looks like ... trend, the researchers added. "Mothers who are overweight teach ... Dr. Michael Mendelson. He is a research fellow at the ...
Breaking Medicine News(10 mins):Health News:Depression Relief Product Receives Top 5-Star Rating from TopConsumerReviews.com 2Health News:RankingBySEO Announces Lawyer Reputation Management Service 2Health News:First Choice Emergency Room Opens New Facility in Friendswood, Texas 2Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2Health News:Kids Born to Overweight Moms May Face Higher Heart Risks as Adults 2
... stillbirths of rodents born to mothers infected with cytomegalovirus// ... loss in newborn children infected in early fetal life. ... ,Estimates place the number of U.S. children born ... is no vaccine or treatment for pregnant women who ...
... evidence to support the link between the common cold ... The study also shows that the link between rhinoviruses ... history of wheezing or asthma. ,Rhinoviruses are ... for at least 50 percent of all common colds. ...
... College of Medicine of Yeshiva University have discovered a ... susceptible to a newly developed molecular targeted therapy. As ... therapy will be able to enroll patients who’ll be ... research was led by Dr. Ari Melnick, assistant professor ...
... about our weight or a bad hair day is ... disorders spend// nearly every waking moment--up to 80 to ... treatment professionals with the Eating Disorders Program at The ... the concern with body shape and size that is ...
... Women’s Health Week will be celebrated May 13-19 this year. ... can take to improve their health. Women often put their ... family members. This week encourages women to be mindful of ... Awareness Day” will be observed on May 15. Sponsored by ...
... According to a report released by International Federation of Red ... by measles//. This disease has so far claimed four lives ... affected by this illness. ,The outbreak began in ... suffering from this infection. There is a steady increase of ...
Cached Medicine News:Health News:CMV Vaccine Prototype Successfully Tested in Guinea Pigs 2Health News:CMV Vaccine Prototype Successfully Tested in Guinea Pigs 3Health News:Children With Asthma Most Affected by Rhinovirus 2Health News:Children With Asthma Most Affected by Rhinovirus 3Health News:Novel Test Identifies Leukemia Patients Likely to Respond to New Therapy 2Health News:Improving Body Image Key to Treating Eating Disorders 2Health News:Improving Body Image Key to Treating Eating Disorders 3Health News:Women’s Health Takes the Spotlight in Ma 2
Bandeau Bra...
Post-Surgical compression garments...
... The Albumin Cobalt Binding (ACB®) Test ... Ischemia Modified Albumin (IMA®) by measuring the ... patient serum sample. First identified in the ... albumin comes in contact with ischemic tissue ...
... Binding (ACB®) Test is a clinical chemistry ... by measuring the cobalt binding capacity of ... identified in the early 1990s, IMA is ... with ischemic tissue in the heart. During ...
Medicine Products: